Ernest B Izevbigie
Biographic Data
| ID | 7916343 |
|---|---|
| NAME | Ernest B Izevbigie |
| GIVEN NAMES | Ernest B |
| FAMILY NAME | Izevbigie |
| SIGNATURE | IZEVBIGIE E B |
| AFFILIATIONS | Jackson State University |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2008 |
| H-INDEX | 0 |
Vernonia amygdalina: Anticancer Activity, Authentication, and Adulteration Detection
Evidence suggests that most chemotherapeutic agents are less effective as treatment in patients with estrogen receptor-negative (ER-) breast carcinomas compared to those with estrogen receptor-positive (ER+) breast carcinomas. Moreover, African American Women (AAW) is disproportionately diagnosed with ER- breast cancer compared to their white counterparts. Novel therapies effective against ER- breast carcinomas are urgently needed to ameliorate t…
Preclinical Assessment of Vernonia amygdalina Leaf Extracts as DNA Damaging Anti-cancer Agent in the Management of Breast Cancer
Breast cancer is the leading cause of death among women between 40 and 55 years of age and is the second overall cause of death among women. Fortunately, the mortality rate from breast cancer has decreased in recent years due to an increased emphasis on early detection and more effective treatments. Despite early detection, conventional and chemotherapeutic methods of treatment, about 7% of women still died every year. Hence, the aim of the prese…
Aqueous Vernomia amygdalina Extracts Alter MCF-7 Cell Membrane Permeability and Efflux
Breast cancer is the second leading cause of cancer related deaths of women in the United States. Several treatment strategies have been developed over the past decade to reduce cancer morbidity and mortality rates. While mortality rates have declined in some ethnic populations, the overall cancer incidence continues to grow. Hence, chemotherapeutic agents are needed to improve cancer treatment outcome. Previous studies show that low concentratio…
No prominent works on this page.
Aqueous Vernomia amygdalina Extracts Alter MCF-7 Cell Membrane Permeability and Efflux
Breast cancer is the second leading cause of cancer related deaths of women in the United States. Several treatment strategies have been developed over the past decade to reduce cancer morbidity and mortality rates. While mortality rates have declined in some ethnic populations, the overall cancer incidence continues to grow. Hence, chemotherapeutic agents are needed to improve cancer treatment outcome. Previous studies show that low concentratio…
Vernonia amygdalina: Anticancer Activity, Authentication, and Adulteration Detection
Evidence suggests that most chemotherapeutic agents are less effective as treatment in patients with estrogen receptor-negative (ER-) breast carcinomas compared to those with estrogen receptor-positive (ER+) breast carcinomas. Moreover, African American Women (AAW) is disproportionately diagnosed with ER- breast cancer compared to their white counterparts. Novel therapies effective against ER- breast carcinomas are urgently needed to ameliorate t…
Preclinical Assessment of Vernonia amygdalina Leaf Extracts as DNA Damaging Anti-cancer Agent in the Management of Breast Cancer
Breast cancer is the leading cause of death among women between 40 and 55 years of age and is the second overall cause of death among women. Fortunately, the mortality rate from breast cancer has decreased in recent years due to an increased emphasis on early detection and more effective treatments. Despite early detection, conventional and chemotherapeutic methods of treatment, about 7% of women still died every year. Hence, the aim of the prese…
Breast cancer (3 works) · Cancer (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Natural Antidiabetic Agents Studies (3 works) · Traditional medicine (3 works) · Vernonia amygdalina (3 works) · Biochemistry (2 works) · Biology (2 works) · Cancer Research (2 works)